Adam Cohen
Inova Health Care Services · Inova Schar Cancer Institute · University of Pennsylvania
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adam Cohen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 15:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07831369 · VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent GliomaInova Health Care Services · recruiting · Glioblastoma, Astrocytoma, IDH-Mutant, Grade 4 · principal investigator
- N/ANCT05519774 · Assessment of Cancer Related Brain Fog Using the Test of Strategic LearningInova Health Care Services · completed · Brain Fog · principal investigator
- Ph2NCT04965688 · Biology Guided Therapy for Breast Cancer for ER PositiveInova Health Care Services · terminated · Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer · principal investigator
- Ph2NCT04680468 · Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple MyelomaUniversity of Pennsylvania · active not recruiting · Myeloma · principal investigator
- Ph1NCT02546167 · CART-BCMA Cells for Multiple MyelomaUniversity of Pennsylvania · completed · Multiple Myeloma · principal investigator
- Ph1NCT01789242 · A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain AmyloidosisCriterium, Inc. · completed · Amyloidosis, Systemic Light Chain Amyloidosis · principal investigator
- Ph1/Ph2NCT01580969 · Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent GliomaUniversity of Utah · completed · Recurrent Glioma · principal investigator
- Ph1NCT01007695 · Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a PilotUniversity of Utah · terminated · Cancer · study chair
- Ph1NCT00836225 · Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy VolunteersIonis Pharmaceuticals, Inc. · completed · Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 15:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- An Exploratory Phase 1B Study to Assess the Effects of Merestinib on Bone Metastases in Subjects with Metastatic Breast CancerR21CA226489 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · fiscal years 2018 to 2019 · $160,604 awarded in 2019Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 15:54 UTC. The ranking covers the 200 most relevant of 728 PubMed records, and a shared surname and initials can bring in a namesake. All 728 on PubMed
- Oral rivaroxaban for symptomatic venous thromboembolism.N Engl J Med · 20102,485 citationsRCR 79.2
- Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.N Engl J Med · 20121,815 citationsRCR 65.2
- Oral apixaban for the treatment of acute venous thromboembolism.N Engl J Med · 20131,781 citationsRCR 65.1
- Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.N Engl J Med · 20071,584 citationsRCR 46.7
- 1,261 citationsRCR 37.4
- 1,171 citationsRCR 43.0
- Apixaban for extended treatment of venous thromboembolism.N Engl J Med · 20131,027 citationsRCR 37.1
- Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.N Engl J Med · 2002838 citationsRCR 23.4
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.N Engl J Med · 2020812 citationsRCR 44.9
- Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.Circulation · 2004735 citationsRCR 19.7